CLINICAL_TRIALS
trial_result
· 2009-07-07
Clinical Trial Update: Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly [Phase 3]
Summary
Phase 3 trial evaluating melatonin to prevent delirium in acutely hospitalized elderly patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Delirium | Phase 3 | Status: COMPLETED